Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

High-throughput drug screening model using human pregnane X receptor (hPXR)-mediated dual-luciferase reporter gene technique

A luciferase and reporter gene technology, applied in the fields of molecular biology and pharmacology, can solve problems affecting the expression and adverse effects of metabolic enzymes and transporters

Inactive Publication Date: 2015-05-06
SUN YAT SEN UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, after stimulating PXR, it often produces unexpected adverse effects due to the impact on the expression of metabolic enzymes and transporters.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • High-throughput drug screening model using human pregnane X receptor (hPXR)-mediated dual-luciferase reporter gene technique
  • High-throughput drug screening model using human pregnane X receptor (hPXR)-mediated dual-luciferase reporter gene technique

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Routine culture of HEK293T cells

[0027] HEK293T cells were grown in DMEM high-glucose medium containing 10% fetal bovine serum, 100 U / mL penicillin and streptomycin, and adhered to the wall at 37°C, 5% CO2, and saturated humidity. When the cells grow to 80% ~ 90% confluent, they are digested with 0.25% trypsin digestion solution, the digestion time is 1 ~ 2min, and passaged at 1:3.

Embodiment 2

[0029] Plasmid extraction

[0030] 1) Pick and inoculate the Escherichia coli containing the plasmid in 30 mL LB liquid medium for culture, shake at 37 °C, 260 rpm / min, and shake for 12-16 h to obtain a small shake liquid. Collect the bacteria by centrifuging at 3500–5000 g for 30 min at room temperature.

[0031] 2) Discard the medium supernatant. Add 250 μL Solution I / RNaseA resuspension solution and vortex to completely suspend the cells.

[0032] 3) Add 250 μL of Solution II lysate to the resuspension mixture, immediately invert and mix 4-6 times, then place the mixture at room temperature for 2 minutes to increase the yield, until the solution is clear. Avoid vigorous mixing of the lysate and the lysis reaction should not exceed 5 min.

[0033] 4) Add 300 μL Solution III neutralizing solution, and gently invert the centrifuge tube several times until a white flocculent precipitate is formed. high speed centrifugation

[0034] 5) Carefully transfer the supernatant to ...

Embodiment 3

[0042] According to the optimal transfection conditions obtained, HEK293 cells transiently transfected with PXR expression plasmids, reporter gene plasmids, and internal reference plasmids were given corresponding positive drugs, and the dual luciferase activity was detected after drug stimulation for 24 h. The results were as follows: figure 1 As shown, the relative fluorescence intensity increases dose-dependently with the positive drug, and the relative fluorescence intensity of 50 μM Rif can reach about 8.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a high-throughput drug screening model using a human pregnane X receptor (hPXR)-mediated dual-luciferase reporter gene technique. The invention discloses a method for screening a human pregnane X receptor stimulant and an antagonist; by virtue of the method which is a new drug screening method, active drug ligands having regulating effect on a target gene, namely cytochrome CYP450 gene, of the PXR. A human embryonic renal HEK293T cell is subjected to the instantaneous co-transfection of an hPXR expression plasmid, a firefly luciferase reporter gene plasmid and an internal reference renilla luciferase plasmid by virtue of the method. The activities of the firefly luciferase and the renilla luciferase are simultaneously detected to show the regulating effect of the drug on the PXR activity, so as to establish a method for screening the hPXR stimulant and the hPXR antagonist. On one hand, the method can screen out compounds having an hPXR stimulating activity at high throughput from a massive compound library so as to avoid a risk that adverse drugs interact caused by the combined use of new drugs; and on the other hand, the method can screen out compounds having PXR antagonistic activity to inhibit the inducing effect of ligands on drug metabolic enzyme and transporter, so as to reduce the occurrence of adverse DDI and to reverse the drug resistance of anticancer drugs.

Description

technical field [0001] The invention belongs to the field of molecular biology and pharmacology, in particular the invention relates to a method for screening human pregnane X receptor agonists and antagonists, which can be used to screen for the target gene of PXR—cytochrome CYP450 The active drug ligand for the regulation of gene production can be applied to the screening of new drugs. Background technique [0002] PXR belongs to the NR1I subfamily of nuclear receptors. The human PXR gene contains 10 exons and 9 introns, with a total length of about 35kb. In 1998, three research groups independently discovered pregnane-activated receptors, steroid and xenobiotic receptors PXR in humans and mice using homologous cloning and database technology, because they can be activated by high concentrations of progesterone, Hence the name, sometimes also called steroid xenobiotic receptor (SXR). The functional proteins that PXR can regulate involve drug distribution, metabolism, and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85C12N15/53C12N5/10C12Q1/68C12Q1/66C12Q1/02
Inventor 钟国平黄民庄嘉琅陈攀黎玉华
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com